Literature DB >> 15274032

Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients.

G J Wiehahn1, G P Bosch, R R du Preez, H W Pretorius, M Karayiorgou, J L Roos.   

Abstract

A hemizygous deletion of the q11 band on chromosome 22 occurs in 1 of every 5,950 live births (0.017%). The deletion is mediated by low copy repeats (LCRs) flanking this locus. Presence of the deletion is associated with variable phenotypic expression, which can include distinctive facial dysmorphologies, congenital heart disease and learning disabilities. An unusually high percentage of individuals with this deletion (25-30%) have been described to develop schizophrenia or schizoaffective disorder. In previous studies, the prevalence of the 22q11 deletion in patients with schizophrenia was found to be approximately 2% in Caucasian adults and 6% in childhood-onset cases. Both these frequencies represent a dramatic increase from the prevalence of the deletion in the general population. In this study, we investigate the occurrence of the 22q11 deletion in an independent sample of schizophrenic patients of Afrikaner origin. We first ascertained a sample of 85 patients who meet full diagnostic criteria for schizophrenia for presence of two or more of the clinical features associated with presence of the 22q11 deletion. A group of six patients (7%) met these criteria. This group was subjected to fluorescent in situ hybridization (FISH) and presence of the 22q11 deletion was confirmed for two subjects. Our study therefore confirms the previously reported rate of 2% frequency of the 22q11 deletion in adult schizophrenic patients and provides a two-stage screening protocol to identify these patients. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15274032     DOI: 10.1002/ajmg.b.20168

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

Review 1.  Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.

Authors:  Anne S Bassett; Stephen W Scherer; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

2.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

3.  Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia.

Authors:  Mechteld L C Hoogendoorn; Jacob A S Vorstman; Gholam R Jalali; Jean-Paul Selten; Richard J Sinke; Beverly S Emanuel; René S Kahn
Journal:  Schizophr Res       Date:  2007-10-26       Impact factor: 4.939

4.  Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome.

Authors:  Anne S Bassett; Oana Caluseriu; Rosanna Weksberg; Donald A Young; Eva W C Chow
Journal:  Biol Psychiatry       Date:  2007-01-09       Impact factor: 13.382

5.  A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia.

Authors:  Sagiv Shifman; Anat Levit; Mao-Liang Chen; Chia-Hsiang Chen; Michal Bronstein; Avraham Weizman; Benjamin Yakir; Ruth Navon; Ariel Darvasi
Journal:  Hum Genet       Date:  2006-06-17       Impact factor: 4.132

6.  Psychotic features as the first manifestation of 22q11.2 deletion syndrome.

Authors:  So Dahm Kook; Suk Kyoon An; Kyung Ran Kim; Woo Jung Kim; Eun Lee; Kee Namkoong
Journal:  Psychiatry Investig       Date:  2010-02-19       Impact factor: 2.505

7.  Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.

Authors:  Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

Review 8.  Schizophrenia and 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

9.  Evidence for involvement of GNB1L in autism.

Authors:  Ying-Zhang Chen; Mark Matsushita; Santhosh Girirajan; Mark Lisowski; Elizabeth Sun; Youngmee Sul; Raphael Bernier; Annette Estes; Geraldine Dawson; Nancy Minshew; Gerard D Shellenberg; Evan E Eichler; Mark J Rieder; Deborah A Nickerson; Debby W Tsuang; Ming T Tsuang; Ellen M Wijsman; Wendy H Raskind; Zoran Brkanac
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-11-16       Impact factor: 3.568

10.  Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.

Authors:  Laurens J M Evers; Therese A M J van Amelsvoort; Jaap A Bakker; Mariken de Koning; Marjan Drukker; Leopold M G Curfs
Journal:  Psychopharmacology (Berl)       Date:  2015-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.